903 total citations 21 papers, 706 citations indexed
About
Levin Va is a scholar working on Genetics, Oncology and Neurology.
According to data from OpenAlex, Levin Va has authored 21 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Oncology and 3 papers in Neurology. Recurrent topics in Levin Va's work include Glioma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (7 papers) and Brain Metastases and Treatment (3 papers). Levin Va is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (7 papers) and Brain Metastases and Treatment (3 papers). Levin Va collaborates with scholars based in United States. Levin Va's co-authors include Wilson Cb, Wherly P. Hoffman, Yuji Saito, Juàn Fueyo, Candelaria Gomez‐Manzano, Lara McGrath, Pamela Silver, Michael Neely, David C. Crafts and Edwin Boldrey and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Levin Va
21 papers
receiving
624 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Levin Va's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levin Va with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levin Va more than expected).
This network shows the impact of papers produced by Levin Va. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levin Va. The network helps show where Levin Va may publish in the future.
Co-authorship network of co-authors of Levin Va
This figure shows the co-authorship network connecting the top 25 collaborators of Levin Va.
A scholar is included among the top collaborators of Levin Va based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Levin Va. Levin Va is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Fueyo, Juàn, et al.. (1996). Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.. PubMed. 13(8). 1615–9.57 indexed citations
2.
Va, Levin, et al.. (1987). Does chemotherapy benefit the patient with a central nervous system glioma?. PubMed. 1(9). 29–36, 40.19 indexed citations
3.
Va, Levin, et al.. (1986). Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme.. PubMed. 70(6). 739–43.21 indexed citations
4.
Va, Levin, et al.. (1984). PCNU treatment for recurrent malignant gliomas.. PubMed. 68(7-8). 969–73.26 indexed citations
5.
Va, Levin, et al.. (1981). Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.. PubMed. 65 Suppl 2. 83–8.1 indexed citations
6.
Va, Levin, et al.. (1981). Drug delivery to CNS tumors.. PubMed. 65 Suppl 2. 19–25.16 indexed citations
7.
Va, Levin, et al.. (1980). Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.. PubMed. 64(12). 1179–205.105 indexed citations
8.
Va, Levin, et al.. (1980). Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.. PubMed. 64(2-3). 237–44.106 indexed citations
9.
Va, Levin, et al.. (1978). Pharmacokinetics of BCNU in man: a preliminary study of 20 patients.. PubMed. 62(9). 1305–12.56 indexed citations
10.
Va, Levin, et al.. (1976). BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.. PubMed. 60(3). 243–9.16 indexed citations
11.
Cb, Wilson, Kate Wheeler, Levin Va, Marc K. Rosenblum, & Marvin Barker. (1976). Brain tumor chemotherapy: translation of laboratory experiments into clinical trials.. PubMed. 101. 214–6.1 indexed citations
12.
Va, Levin, et al.. (1976). Intracarotid BCNU (NSC-409962): a toxicity study in six rhesus monkeys.. PubMed. 60(5). 541–5.29 indexed citations
13.
Va, Levin & Wilson Cb. (1976). Nitrosourea chemotherapy for primary malignant gliomas.. PubMed. 60(6). 719–24.36 indexed citations
14.
Va, Levin. (1976). Pharmacological principles of brain tumor chemotherapy.. PubMed. 15. 315–25.16 indexed citations
15.
Va, Levin. (1975). A pharmacologic basis for brain tumor chemotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(1). 57–61.34 indexed citations
16.
Va, Levin & Wilson Cb. (1975). Chemotherapy: the agents in current use.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(1). 63–7.26 indexed citations
17.
Va, Levin, David C. Crafts, Wilson Cb, et al.. (1975). Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors.. PubMed. 59(2 Pt 1). 327–31.11 indexed citations
18.
Va, Levin, et al.. (1972). Propagation of blast waves in a combustible gas. 17(4). 529–537.86 indexed citations
19.
Va, Levin, et al.. (1970). The pathophysiology of obstructive hydrocephalus in the monkey.. PubMed. 95. 274–6.1 indexed citations
20.
Va, Levin, et al.. (1969). Methotrexate permeability and steady-state distribution in the murine ependymoblastoma.. PubMed. 94. 294–6.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.